semaglutide fda label Says to Drop Suicide Warning From GLP-1 Drug Labels 🎉Exciting news that Semaglutide is

The dramatic report by the WHO has shown that by 2050, drug resistance could catch up to cancer and sufficiently damage the economy if actions are not taken (World Health Organization, 2019)

People use them to support focus, memory, attention, motivation, mood, relaxation, alertness, and stress resilience

Eligible patients include those with severe obesity and a body mass index (BMI) of at least 40 kg/m, as well as those with serious obesity and a BMI of at least 35 kg/m

Preclinical studies suggest that GLP-1RAs have a beneficial effect on major NAFLD histological outcomes, i.e., hepatic steatosis and inflammation, through multiple intrahepatic mechanisms, including increased fatty acid -oxidation, activation of autophagy, suppression of inflammation, and oxidative stress